Literature DB >> 8352624

Pattern of familial aggregation of vitiligo.

P P Majumder1, J J Nordlund, S K Nath.   

Abstract

BACKGROUND AND
DESIGN: Vitiligo is a disorder whose cause is not well understood. This study was undertaken to clarify whether genetic factors are involved in the pathogenesis of vitiligo. Data on 160 white kindreds living in the United States have been collected. Each family was ascertained through a proband afflicted with vitiligo. The nature and extent of familial aggregation and other relevant epidemiologic features have been determined.
RESULTS: The mean age at onset of vitiligo is about 19 years in male and about 24 years in female individuals. The percentage of probands reporting one or more first-degree relatives also afflicted with vitiligo is 20%. Children of probands are found to be afflicted about 1.7 times more commonly than other first-degree relatives. The relative risk (RR) for vitiligo is about 7 for parents, about 12 for siblings, and about 36 for children. For second-degree relatives, the RR varies between 1 and 16. Relative risks for all first- and second-degree relatives, except uncles and grandsons, are significant at the 5% level. In families in which one or more relatives of the proband are afflicted with vitiligo, the intrafamilial correlation of ages at onset of vitiligo is moderate (0.6). No statistically significant effect (at the 5% level) of parental age at first childbirth was seen on the proportion of offspring afflicted with vitiligo. No significant association of some commonly related diseases (eg, thyroid disorder or alopecia areata) was observed with vitiligo or with a family history of vitiligo.
CONCLUSIONS: The extent of familial aggregation of vitiligo is statistically significant. The pattern of relationship between RR and degree of kinship indicates involvement of genetic factors, although it is not consistent with single-locus mendelian transmission.

Entities:  

Mesh:

Year:  1993        PMID: 8352624

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  26 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis.

Authors:  Kiyotaka Nakamagoe; Jun-Ichi Furuta; Ayako Shioya; Akira Tamaoka
Journal:  BMJ Case Rep       Date:  2009-12-09

3.  Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis.

Authors:  Richard A Spritz; Katherine Gowan; Dorothy C Bennett; Pamela R Fain
Journal:  Am J Hum Genet       Date:  2004-01       Impact factor: 11.025

Review 4.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

5.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

Review 6.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

7.  Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.

Authors:  S K Nath; J A Kelly; B Namjou; T Lam; G R Bruner; R H Scofield; C E Aston; J B Harley
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

Review 8.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Genetic epidemiology of vitiligo: multilocus recessivity cross-validated.

Authors:  S K Nath; P P Majumder; J J Nordlund
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

10.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.